Login  /  Register  | 3 premium articles left before you must register.

Amarin shares lower on speculation

Published 09/12/2012 12:00 AM
Updated 09/11/2012 11:29 PM

The shares of Amarin Corp. plc, which has research-and-development headquarters in Groton, fell sharply Tuesday after the company disclosed that regulators have not yet decided whether to grant the maximum five-year protection from generic competition for its heart drug Vascepa.

Drugs like Vascepa that are designated as new chemical entities usually enjoy a five-year period of protection, so the lack of quick action by the U.S. Food and Drug Administration led to speculation that regulators might opt for three-year exclusivity.

The stock finished the day down about 6 percent, and analysts predicted more volatility until the FDA ruling is made public.

Town News

Visit Zip06
Submit Your:  Submit Your News Submit Your Photos Submit Your Events
Most Recent Poll
Harvard has received some unwelcome attention recently over a cheating scandal potentially involving at least 125 students. How common do you think cheating is on American campuses?
If it's happening at Harvard, it's happening everywhere.
39%
Some students will always cheat but I don't think it's a widespread problem.
24%
This is a huge problem and it's society's fault for emphasizing the grade at the expense of an enriching learning environment.
33%
I'm a student and I cheat all the time. It's part of the college experience.
5%
Number of votes: 368

No current items found